Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 4, 2004, Pages 477-483

  Chuah, Chin Tek ^a   Chee, S P ^a   Fong, K S ^a   Por, Y M ^a   Choo, C T ^a   Luu, C ^b   Seah, L L ^a  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

Conjunctiva dehiscence; Exposure; Implant; Socket infection

Indexed keywords

ACRYLIC ACID; GLASS; HYDROXYAPATITE; ROSEOLIC ACID; SILICONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CHILD; COMPARATIVE STUDY; CONJUNCTIVA; ENUCLEATION; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; HYDROXYAPATITE IMPLANT; IMPLANT EXPOSURE; IMPLANT EXTRUSION; IMPLANT MIGRATION; MAJOR CLINICAL STUDY; MALE; NON INTEGRATED IMPLANT; ORBIT IMPLANT; ORBIT INFECTION; PROSTHESIS FAILURE; SINGAPORE NATIONAL EYE CENTER; STATISTICAL ANALYSIS; STUDENT T TEST; WOUND DEHISCENCE;

EID: 4644293775     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Perry AC. Advances in enucleation. Ophthalmol Clin North Am 1991;4:173-82.
2. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11:77-88.
3. Moshfeghi DA, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol 2000;44:277-301.
4. Jordan DR, Gilberg S, Mawn L, Brownstein S, Grahovac SZ. The synthetic hydroxyapatite implant: a report of 65 patients. Ophthal Plast Reconstr Surg 1998;14:250-5.
5. Rubin PA, Popham JK, Bilyk JR, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:96-103.
6. Shields CL, Shields JA, DePotter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994;78:702-6.
7. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants: Report of six cases. Ophthalmology 1992;99:831-6.
8. Shields CL, Shields JA, Potter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol 1992;110:333-8.
9. Fong KS, Choo CT. Hydroxyapatite orbital implants - our local experience. Ann Acad Med Singapore 1997;26:405-8.
10. Perry AC. Integrated orbital implants. Adv Ophthalmic Plast Reconstr Surg 1990;8:75-81.
11. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
12. Remulla HD, Rubin PA, Shore JW, Sutula FC, Townsend DJ, Woog JJ, et al. Complications of porous spherical orbital Implants. Ophthalmology 1995;102:586-93.
13. Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000;107:940-6.
14. Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison P. Long-term follow-up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:1287-92.
15. Allen L. The argument against imbricating the rectus muscles over spherical orbital implants after enucleation. Ophthalmology 1983;90:1116-20.
16. Dutton JD. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
17. Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthal Plast Reconstr Surg 1996;12:18-31.
18. Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
19. Kim YD, Goldberg RA, Shorr N, Steinsapir KD. Management of exposed hydroxyapatite orbital implants. Ophthalmology 1994;101:1709-15.
20. Christmas NJ, Gordon CD, Murray TG, Tse D, Johnson T, Garonzik S, et al. Intraorbital implants after enucleation and their complications. Arch Ophthalmol 1998;116:1199-203.